SARA KIERNAN: Open Payments
NPI 1730729773 · FREEHOLD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,823 in 60 payments from 27 companies in 2025. Trend: 2023 $131 · 2024 $197 · 2025 $1,823
Food & beverage: $1,003Long term medical supply or device loan: $698Education: $122
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $848 |
| PFIZER INC. | 5 | $101 |
| Gilead Sciences, Inc. | 1 | $100 |
| Merck Sharp & Dohme LLC | 4 | $84 |
| Daiichi Sankyo Inc. | 3 | $76 |
| ABBVIE INC. | 4 | $62 |
| Eisai Inc. | 3 | $56 |
| Pharmacosmos Therapeutics Inc. | 3 | $53 |
| PharmaEssentia USA Corporation | 3 | $52 |
| GlaxoSmithKline, LLC. | 2 | $36 |
Products named: KISQALI, Trodelvy, KEYTRUDA, Enhertu, Lenvima, MONOFERRIC, BESREMI, Fabhalta.
Industry payments across NJ — which companies pay providers there.
